| 11. |
There is little high-quality evidence to support the belief that clinical trial participation improves outcomes among patients with cancer, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 12. |
Fluoxetine, sertraline, venlafaxine: no CYP3A4 inhibitory effects |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 14-14
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 13. |
ACE inhibition reduces risk of graft thrombosis in CABG? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 14. |
Combining magnesium hydroxide with ibuprofen reduces the GI tolerability of ibuprofen, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 15. |
Neither olanzapine nor risperidone appear to be associated with significant changes in insulin sensitivity, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 16. |
Regulatory news from the EU |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 17. |
Product Introductions |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1422,
2004,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
